Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
This study demonstrates how a diversity of muscle patterns are currently treated in routine practice where the primary goal was related to the lower limb and highlights important issues for further debate, such as potential underdosing and the need to balance upper and lower limb priorities when devising a treatment plan.
Authors
- Jorge Jacinto (ORCID: https://orcid.org/0000-0002-3428-2312)
- Richard D. Zorowitz (ORCID: https://orcid.org/0000-0001-8938-786X)
- Stephen A. Ashford (ORCID: https://orcid.org/0000-0001-5541-7063)
- Pascal Maisonobe (ORCID: https://orcid.org/0009-0004-3469-7261)
- Christian Hannes (ORCID: https://orcid.org/0000-0001-5664-4524)
- Alberto Esquenazi (ORCID: https://orcid.org/0000-0003-0698-6424)
- Mathieu Beneteau
Institutions
- Ipsen (France) (FR)
- Georgetown University (US)
- Thomas Jefferson University Hospital (US)
- London North West Healthcare NHS Trust (GB)
- Northwick Park Hospital (GB)
- MedStar Georgetown University Hospital (US)
- Ipsen (Germany) (DE)
- Moss Rehabilitation Hospital (US)
- Centro de Medicina de Reabilitacao do Alcoitão (PT)
- MedStar Health (US)
Publication Details
- Journal
- Journal of Rehabilitation Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.2340/jrm.v57.42605
- Citations
- 5
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 6.95
Funders
- SPR Therapeutics
- Shionogi
- Ipsen
- Allergan